FDA released a final guidance "Benefit-Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications 510(k) with Different Technological Characteristics" dated Sept. 25, 2018. This guidance applies only to devices with similar intended use and if the different technological characteristics do not raise different questions of Safety and Effectiveness. Read the full guidance at this link.
Thank you for your interest! To view our Premium or Standards Navigator content, please click here to select the plan that best fits your needs.